Remove companies nektar-therapeutics
article thumbnail

Nektar Says Eli Lilly Botched Autoimmune Drug Trials

Law 360

Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's prospects after it acquired a company with a competing drug.

40